AstraZeneca, Pozen Clear E.U. Approval Hurdle for Arthritis Drug Vimovo
AstraZeneca and Pozen announced Monday that their pain reliever Vimovo for the treatment of arthritis had received positive agreement for approval by the 23 E.U. nations. Vimovo is a combination drug that reduces the risk of ul…